A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2013
12/28/2013	CA2821000A1 Medical devices based on cellulose
12/28/2013	CA2820371A1 Medicated particulate animal feed supplements and methods of preparation
12/27/2013	WO2013192630A1 Foaming oral care formulation and system and method of forming and using same
12/27/2013	WO2013192609A1 Mesoporous oxide nanoparticles and methods of making and using same
12/27/2013	WO2013192566A1 Itraconazole compositions and dosage forms, and methods of using the same
12/27/2013	WO2013192493A1 Nanoparticles of indirubin, derivatives thereof and methods of making and using same
12/27/2013	WO2013192310A1 Mass production and size control of nanoparticles through controlled microvortices
12/27/2013	WO2013192248A1 Progesterone formulations
12/27/2013	WO2013192215A1 Compositions and methods for diminishing an immune response
12/27/2013	WO2013192190A1 Liposome formulations
12/27/2013	WO2013192066A1 Chewing gum product and method of production thereof
12/27/2013	WO2013191668A1 Compositions preventing hypertension comprising soluplus
12/27/2013	WO2013191319A1 Method for preparing granule or pill containing extract in high concentration
12/27/2013	WO2013191236A1 Composition for improving and/or treating central nervous system degenerative disease
12/27/2013	WO2013191187A1 Adhesive preparation composition obtained by blending drug, organic solvent, lipophilic ointment base, and powder
12/27/2013	WO2013191158A1 Percutaneous absorption promoter and skin patch comprising same
12/27/2013	WO2013191128A1 Skin patch
12/27/2013	WO2013190445A1 Inhalable formulations for removal of viscous secretions from the respiratory tract
12/27/2013	WO2013190240A1 Multi-compartment material for the thermally stimulated delivery of substances of interest, preparation method thereof and uses of same
12/27/2013	WO2013190151A1 Pharmaceutical composition comprising fingolimod
12/27/2013	WO2013190111A1 Pharmaceutical composition of moxifloxacin hydrochloride and preparation method
12/27/2013	WO2013190098A1 Formulations for the preparation of immediate-release tablets for oral use containing low-dose mifepristone for the treatment of endometriosis, tablets thus obtained and their preparation process
12/27/2013	WO2013190097A1 Formulations for the preparation of immediate-release tablets for oral administration containing low-dose mifepristone, tablets thus obtained and their preparation process
12/27/2013	WO2013189988A1 Tablet formulation comprising a peptide and a delivery agent
12/27/2013	WO2013189800A1 Cisatracurium and beta-cyclodextrin derivative compositions
12/27/2013	WO2013189776A1 Active ingredient-containing solid dispersions based on diethylaminoethyl methacrylate copolymers
12/27/2013	WO2013189477A1 Emulsion for pharmaceutical use and method for the production thereof
12/27/2013	WO2013189472A1 Emulsion for pharmaceutical use and method for the production thereof
12/27/2013	WO2013189305A1 Valsartan-amlodipine compound solid preparation and preparation method therefor
12/27/2013	WO2013189282A1 Polypeptide-medicine-slow-releasing microsphere preparation and preparation method therefor
12/27/2013	WO2013188999A1 Application of inula lineariifolia lactone a in preparation of medicine for treating multiple sclerosis
12/27/2013	WO2013188996A1 Application of inula lineariifolia lactone a in preparation of medicine for treating myocarditis
12/27/2013	WO2013188979A1 Mucoadhesive nanoparticle delivery system
12/27/2013	WO2013188926A1 Method and composition for delivering a compound through a biological barrier
12/27/2013	WO2013166131A3 Orally disintegrating tablet
12/27/2013	WO2013153550A3 Reverse thermal hydrogel preparations for use in the treatment of disorders of the urothelium
12/27/2013	WO2013136346A3 Taste masking pharmaceutical orally dissolving strips of lornoxicam
12/27/2013	WO2013128276A3 Tamper resistant immediate release formulations
12/27/2013	WO2013093630A3 Gelatin/alginate delayed release capsules comprising omega-3 fatty acids, and methods and uses thereof
12/27/2013	WO2013049328A9 Di-aliphatic substituted pegylated lipids
12/27/2013	WO2013032709A3 Systems and methods for shell encapsulation
12/27/2013	WO2011123836A3 Pharmaceutical formulations for the treatment of overactive bladder
12/27/2013	CA2877169A1 Pharmaceutical composition of moxifloxacin hydrochloride and preparation method
12/27/2013	CA2877051A1 Mucoadhesive nanoparticle delivery system
12/27/2013	CA2876968A1 Soluble estradiol capsule for vaginal insertion
12/27/2013	CA2876964A1 Progesterone formulations
12/27/2013	CA2876947A1 Transdermal hormone replacement therapies
12/27/2013	CA2876939A1 Formulations for the preparation of immediate-release tablets for oral use containing low-dose mifepristone for the treatment of endometriosis, tablets thus obtained and their preparation process
12/27/2013	CA2876935A1 Formulations for the preparation of immediate-release tablets for oral administration containing low-dose mifepristone, tablets thus obtained and their preparation process
12/27/2013	CA2876909A1 Itraconazole compositions and dosage forms, and methods of using the same
12/27/2013	CA2876907A1 Compounds from the fruits of acrocomia crispa and acrocomia aculata against inflammation and oxidative stress
12/27/2013	CA2876495A1 Peptide conjugated particles
12/27/2013	CA2875454A1 Composition for patch preparation comprising drug, organic solvent, lipophilic mass base, and powder
12/26/2013	US20130345649 Self-Heating Patch
12/26/2013	US20130345280 Methods And Compositions Employing Bicifadine For Treating Disability Or Functional Impairment Associated With Acute Pain, Chronic Pain, Or Neuropathic Disorders
12/26/2013	US20130345274 Allantoin-containing skin cream
12/26/2013	US20130345265 Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient
12/26/2013	US20130345260 High Viscosity Liquid Controlled Delivery System and Medical or Surgical Device
12/26/2013	US20130345236 Pharmaceutical compositions providing enhanced drug concentrations
12/26/2013	US20130345160 Glycyrrhizin high-concentration preparation
12/26/2013	US20130345150 Ophthalmic composition
12/26/2013	US20130344184 Materials and methods for treatment and diagnosis of disorders associated with oxidative stress
12/26/2013	US20130344158 Therapeutic Polymeric Nanoparticles with mTOR Inhibitors and Methods of Making and Using Same
12/26/2013	US20130344156 Pharmaceutical compositions of hydrophobic surface-modified active substance microparticles for inhalation
12/26/2013	US20130344155 Fenofibrate formulation
12/26/2013	US20130344152 Peroxide dispersions
12/26/2013	US20130344151 Solid pharmaceutical composition comprising telithromycin
12/26/2013	US20130344150 Direct compression tablets of otilonium
12/26/2013	US20130344149 Oral Dosage Forms for Modified Release Comprising Tasocitinib
12/26/2013	US20130344148 Oral Composition
12/26/2013	US20130344147 Tablet-formed pharmaceutical composition for oral administration and method for producing same
12/26/2013	US20130344146 Dry formulations of aripiprazole
12/26/2013	US20130344143 Formulations of nonopioid and confined opioid analgesics
12/26/2013	US20130344142 Misuse preventative, controlled release formulation
12/26/2013	US20130344141 Concentration and mental performance amplifying formulation
12/26/2013	US20130344132 Sustained-release liposomal anesthetic compositions
12/26/2013	US20130344130 Smart, Self-Decontaminating Polymer and Method for Inhibiting The Growth Of A Bacteria and Fungus
12/26/2013	US20130344128 Method for treating ocular demodex
12/26/2013	US20130344127 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
12/26/2013	US20130344125 Drug delivery device
12/26/2013	US20130344118 Nanoparticle Fabrication Methods, Systems, and Materials
12/26/2013	US20130344117 Pegylated polyplexes for polynucleotide delivery
12/26/2013	US20130344116 Oral particle consisting of an amorphous structure and a submicron domain
12/26/2013	US20130344115 Method for repairing and proliferating cartilage tissue and method of cartilage defect treatment
12/26/2013	US20130344114 Composition for repairing cartilage tissue and method for making the same
12/26/2013	US20130344113 Iron Fortified Food Product and Additive
12/26/2013	US20130344027 Multi-functional polymeric materials and their uses
12/26/2013	US20130344007 Frankincense chewing gum
12/26/2013	US20130343997 Metal Coating of Rare Earth Nano-Phosphors and Uses Thereof
12/26/2013	US20130343996 Graphite-coated magnetic nanoparticles
12/25/2013	EP2676961A1 Combination drugs comprising aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes
12/25/2013	EP2676960A1 Combination drugs comprising aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes
12/25/2013	EP2676959A1 Combination drugs comprising aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes
12/25/2013	EP2676691A2 Delivery of viscous formulations by needle-free injection
12/25/2013	EP2676680A1 Use of hydrophobin polypeptides as penetration enhancers
12/25/2013	EP2676677A1 Highly concentrated anti-cd40 antibody pharmaceutical preparation
12/25/2013	EP2676667A1 Polyethylene glycol colonic purgative composition
12/25/2013	EP2676665A1 Use of -mangostin in preparation of medicaments for treating alzheimer's disease
12/25/2013	EP2676663A2 Transdermal delivery system containing galantamine or salts thereof
12/25/2013	EP2676662A1 Polymeric composition containing mineral fillers, for improving skin wound healing

1 ... 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 ... 2991